Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home
Share
Compartir

Limited Voluntary Recall on Rabies Vaccine Batch

Posted: April 21, 2010

syringe and vials of medicine

RabAvert Kit Batch #458011A, Diluent Vial Batch #927011

Novartis Vaccines is implementing a voluntary market withdrawal of this single batch as the stopper and the metal crimp dislodge from the vial completely when removing the protective cap. A low percentage of diluent vials exhibit this issue. This is a precautionary action taken by Novartis as they have no evidence that the quality of the diluent is compromised as long as the stopper is not removed from the diluent vial. For patients who have received vaccine from this batch, no additional actions, such as revaccination, are required.

The vial of lyophilized rabies vaccine contained in these kits is not affected, but all RabAvert should be returned as complete kits. Only the above-listed batch is subject to this voluntary market withdrawal; all other RabAvert batches are unaffected and safe for use. Customers are requested to contact Novartis Vaccines Customer Service to arrange for product return.

For additional information, see:
Novartis RabAvert Customer Letter [PDF - 61 KB]

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • New Hours of Operation
    8am-8pm ET/Monday-Friday
    Closed Holidays
  • cdcinfo@cdc.gov
We help prevent rabies
CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO